You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: February 29, 2024

Aurobindo Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for AUROBINDO, and what generic and branded alternatives to AUROBINDO drugs are available?

AUROBINDO has four hundred and eighty-three approved drugs.

There are twenty tentative approvals on AUROBINDO drugs.

Drugs and US Patents for Aurobindo

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma FAMOTIDINE famotidine TABLET;ORAL 206531-001 Apr 26, 2016 OTC No No ⤷  Try a Trial ⤷  Try a Trial
Aurobindo Pharma Ltd NIACIN niacin TABLET, EXTENDED RELEASE;ORAL 209236-001 Feb 1, 2018 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
Aurobindo Pharma Ltd ARMODAFINIL armodafinil TABLET;ORAL 206069-004 Dec 7, 2018 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
Aurobindo Pharma VENLAFAXINE HYDROCHLORIDE venlafaxine hydrochloride TABLET;ORAL 090555-004 Apr 7, 2010 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
Aurobindo Pharma MINOCYCLINE HYDROCHLORIDE minocycline hydrochloride CAPSULE;ORAL 065470-001 Mar 11, 2008 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Aurobindo

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Aurobindo Pharma Usa MAXZIDE hydrochlorothiazide; triamterene TABLET;ORAL 019129-001 Oct 22, 1984 4,105,783 ⤷  Try a Trial
Aurobindo Pharma Usa MAXZIDE hydrochlorothiazide; triamterene TABLET;ORAL 019129-001 Oct 22, 1984 4,444,769 ⤷  Try a Trial
Aurobindo Pharma Usa MAXZIDE-25 hydrochlorothiazide; triamterene TABLET;ORAL 019129-003 May 13, 1988 4,444,769 ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Paragraph IV (Patent) Challenges for AUROBINDO drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Delayed-release Tablets 20 mg ➤ Subscribe 2015-06-03
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.